A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma

被引：62

作者：

Adélaïde, J

Pérot, C

Gelsi-Boyer, V

Pautas, C

Murati, A

Copie-Bergman, C

Imbert, M

Chaffanet, M

Birnbaum, D

Mozziconacci, MJ ^{[1
]}

机构：

[1] Inst J Paoli I Calmettes, Dept Mol Oncol, Inst Cancerol Marseille, F-13009 Marseille, France

[2] INSERM, U599, F-13258 Marseille, France

[3] Hop St Antoine, Lab Cytogenet, F-75571 Paris, France

[4] Inst J Paoli I Calmettes, Dept BioPathol, F-13009 Marseille, France

[5] Univ Mediterranee, Marseille, France

[6] Hop Henri Mondor, Serv Hematol Clin, F-94010 Creteil, France

[7] Hop Henri Mondor, Dept Pathol, F-94010 Creteil, France

[8] Hop Henri Mondor, Hematol Lab, F-94010 Creteil, France

来源：

LEUKEMIA | 2006年 / 20卷 / 03期

关键词：

D O I：

10.1038/sj.leu.2404104

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：536 / 537

页数：2

共 5 条

[1] The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene [J].

Bousquet, M ;

Quelen, C ;

De Mas, V ;

Duchayne, E ;

Roquefeuil, B ;

Delsol, G ;

Laurent, G ;

Dastugue, N ;

Brousset, P .

ONCOGENE, 2005, 24 (48) :7248-7252

[2] Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case [J].

Heiss, S ;

Erdel, M ;

Gunsilius, E ;

Nachbaur, D ;

Tzankov, A .

HUMAN PATHOLOGY, 2005, 36 (10) :1148-1151

[3] PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation [J].

Murati, A ;

Gelsi-Boyer, V ;

Adélaïde, J ;

Perot, C ;

Talmant, P ;

Giraudier, S ;

Lodé, L ;

Letessier, A ;

Delaval, B ;

Brunel, V ;

Imbert, M ;

Garand, R ;

Xerri, L ;

Birnbaum, D ;

Mozziconacci, M ;

Chaffanet, M .

LEUKEMIA, 2005, 19 (09) :1692-1696

[4] The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2 [J].

Reiter, A ;

Walz, C ;

Watmore, A ;

Schoch, C ;

Blau, I ;

Schlegelberger, B ;

Berger, U ;

Telford, N ;

Aruliah, S ;

Yin, JA ;

Vanstraelen, D ;

Barker, HF ;

Taylor, PC ;

O'Driscoll, A ;

Benedetti, F ;

Rudolph, C ;

Kolb, HJ ;

Hochhaus, A ;

Hehlmann, R ;

Chase, A ;

Cross, NCP .

CANCER RESEARCH, 2005, 65 (07) :2662-2667

[5] The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders:: Status report and immediate implications for disease classification and diagnosis [J].

Tefferi, A ;

Gilliland, DG .

MAYO CLINIC PROCEEDINGS, 2005, 80 (07) :947-958

← 1 →